Sarepta Therapeutics (SRPT) SEC Filings & 10K Form

$133.66
+3.03 (+2.32%)
(As of 05/3/2024 ET)

Recent Sarepta Therapeutics SEC Filings

DateFilerForm TypeView
05/01/2024
3:01 PM
Sarepta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2024
3:05 PM
Sarepta Therapeutics (Filer)
Form DEF 14A
03/11/2024
7:00 PM
Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:00 PM
Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:00 PM
Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:00 PM
Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:00 PM
Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:02 PM
Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
6:03 PM
Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/08/2024
4:38 PM
Sarepta Therapeutics (Subject)
Wigzell Hans Lennart Rudolf (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
7:00 PM
Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
7:00 PM
Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
7:00 PM
Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
7:00 PM
Mayo Stephen (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
7:00 PM
Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM
Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM
Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM
Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM
Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM
Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM
BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM
Chambers Michael Andrew (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM
Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM
Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM
Mayo Stephen (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM
Nicaise Claude (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
4:34 PM
Mayo Stephen (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
6:55 PM
Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
6:42 PM
Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
3:47 PM
Arif Bilal (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2024
12:34 PM
JANUS HENDERSON GROUP PLC (Filed by)
Sarepta Therapeutics (Subject)
Form SC 13G/A
01/26/2024
4:26 PM
BlackRock Inc. (Filed by)
Sarepta Therapeutics (Subject)
Form SC 13G/A
01/08/2024
11:08 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2023
7:00 PM
Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
7:00 PM
Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2023
7:00 AM
BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2023
7:00 AM
INGRAM DOUGLAS S (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2023
7:00 AM
Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
7:00 AM
Chambers Michael Andrew (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
7:00 AM
Chambers Michael Andrew (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2023
6:40 AM
Chambers Michael Andrew (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Gold Mania (Ad)

Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).

See his free reveal right here.
08/08/2023
7:00 PM
Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2023
5:25 PM
Sarepta Therapeutics (Subject)
Wigzell Hans Lennart Rudolf (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/02/2023
3:02 PM
Sarepta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/22/2023
3:49 PM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/22/2023
1:22 PM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2023
7:00 PM
Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SRPT) was last updated on 5/3/2024 by MarketBeat.com Staff

From Our Partners